Faeth Therapeutics, Inc. (FTH)
19.51
+0.71
(+3.78%)
USD |
NASDAQ |
Oct 19, 15:06
Faeth Therapeutics Price to Book Value : 2.914 for Oct. 19, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 16, 2026 | 2.808 |
| October 15, 2026 | 3.077 |
| October 14, 2026 | 2.987 |
| October 13, 2026 | 3.213 |
| October 12, 2026 | 3.473 |
| October 09, 2026 | 3.888 |
| October 08, 2026 | 3.825 |
| October 07, 2026 | 3.722 |
| October 06, 2026 | 4.016 |
| October 05, 2026 | 4.048 |
| October 02, 2026 | 4.234 |
| October 01, 2026 | 4.222 |
| September 30, 2026 | 4.442 |
| September 29, 2026 | 4.192 |
| September 28, 2026 | 4.148 |
| September 25, 2026 | 4.182 |
| September 24, 2026 | 4.339 |
| September 23, 2026 | 4.712 |
| September 22, 2026 | 4.989 |
| September 21, 2026 | 4.972 |
| September 18, 2026 | 5.153 |
| September 17, 2026 | 5.247 |
| September 16, 2026 | 5.114 |
| September 15, 2026 | 5.283 |
| September 14, 2026 | 5.838 |
| Date | Value |
|---|---|
| September 11, 2026 | 5.592 |
| September 10, 2026 | 5.825 |
| September 09, 2026 | 5.395 |
| September 08, 2026 | 5.855 |
| September 04, 2026 | 5.982 |
| September 03, 2026 | 5.825 |
| September 02, 2026 | 5.843 |
| September 01, 2026 | 5.154 |
| August 31, 2026 | 4.894 |
| August 28, 2026 | 5.054 |
| August 27, 2026 | 5.039 |
| August 26, 2026 | 4.924 |
| August 25, 2026 | 5.156 |
| August 24, 2026 | 5.184 |
| August 21, 2026 | 4.780 |
| August 20, 2026 | 4.794 |
| August 19, 2026 | 4.945 |
| August 18, 2026 | 4.929 |
| August 17, 2026 | 4.894 |
| August 14, 2026 | 4.830 |
| August 13, 2026 | 4.264 |
| August 12, 2026 | 4.388 |
| August 11, 2026 | 4.481 |
| August 10, 2026 | 4.267 |
| August 07, 2026 | 3.643 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Opus Genetics, Inc. | -- |
| Nuvectis Pharma, Inc. | 54.91 |
| ACADIA Pharmaceuticals, Inc. | 2.593 |
| Alnylam Pharmaceuticals, Inc. | 23.27 |
| Anika Therapeutics, Inc. | 1.977 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0001 |
| Price | 19.51 |
| Earnings Yield | -726.0% |
| Market Cap | 504.00M |
| PEGY Ratio | -0.0001 |